US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Tevogen Bio Holdings Inc (TVGN)
Tevogen Bio Holdings Inc (TVGN) ニュース

TVGN

Tevogen Bio (TVGN)

Tevogen Bio Holdings Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:TVGN

1 2 3 4 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2025/01/24	09 : 53	GlobeNewswire Inc.	Tevogen Bio Highlights the Future of AI-Driven Drug Development in Fireside Chat with Microsoft During the J.P. Morgan Healthcare Conference	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/12/27	02 : 21	GlobeNewswire Inc.	Tevogen Bio to Host Panel Discussions “AI In Biopharma: Next Frontier of Medical Innovation” and “Pioneering the Economics of Health: Balancing Access and Outcomes” During J.P. Morgan Healthcare Conference	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/12/23	23 : 38	GlobeNewswire Inc.	Tevogen Bio to Host Panel "AI In Biopharma: Next Frontier of Medical Innovation" During the 43rd Annual J.P. Morgan Healthcare Conference	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/12/19	22 : 30	GlobeNewswire Inc.	Tevogen Bio Strengthens Robust IP Portfolio With Filing of Predictive AI Patent, With the Goal to Establish a Blueprint to Unlock the Full Potential of T Cell Therapies and Accelerate AI Integration to Advance Its Bold Growth Agenda	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/12/18	03 : 32	GlobeNewswire Inc.	Tevogen Bio to Host Panel “Pioneering the Economics of Health: Balancing Access and Outcomes” During the 43rd Annual J.P. Morgan Healthcare Conference	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/12/11	05 : 13	GlobeNewswire Inc.	Tevogen Bio to Attend the 43rd Annual J.P. Morgan Healthcare Conference	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/12/06	01 : 03	GlobeNewswire Inc.	Dr. Ryan Saadi Commends Individuals Who Dedicate Time to Public Service, and Congratulates Mayor Victor Sordillo on His Induction Into the NJ League of Municipalities Hall of Fame	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/11/26	22 : 05	GlobeNewswire Inc.	Tevogen Bio Prepares Organizational Readiness to Support Company’s Growth Strategy	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/11/22	05 : 59	GlobeNewswire Inc.	Tevogen Bio CEO Reflects on Public Support, Reaffirms Preserving Shareholder Value Remains His Priority, and Reinforces Options Including a Potential Share Buyback to Support Company Value	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/11/20	06 : 50	GlobeNewswire Inc.	Tevogen Bio Reports Third Quarter 2024 Financial Results; Highlights Significantly Improved Financial Position, Unreported Asset Value on Balance Sheets, Efficient Business Model	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/11/15	07 : 00	GlobeNewswire Inc.	UPDATE - Tevogen Founder Reflects on Importance of Preserving Shareholder Value While Navigating Growth as it Prepares to File Quarterly Financials	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/11/15	05 : 49	GlobeNewswire Inc.	Tevogen Founder Reflects on Importance of Preserving Shareholder Value While Navigating Growth as it Prepares to File Quarterly Financials	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/11/09	05 : 36	GlobeNewswire Inc.	Tevogen Bio Nears Finalization of Agreement to Enhance R&D and Manufacturing Capabilities; $36 Million Line of Credit Available for Continued Operations	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/11/06	06 : 43	GlobeNewswire Inc.	Tevogen Bio CEO Dr. Ryan Saadi Expresses Gratitude for Prestigious ROI-NJ Recognition, Highlighting Company’s Novel Business Model as Key to Sustainable Success through Patient Affordability	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/11/05	23 : 27	GlobeNewswire Inc.	Tevogen Bio Leverages Microsoft Partnership to Deliver Machine Learning Based Target Identification to Address Human Papilloma Virus (HPV), Advancing TVGN 920	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/11/05	04 : 36	GlobeNewswire Inc.	Tevogen Bio Announces Appointment of Anthony Tarantino as Patient Advocate to Enhance Community Engagement and Patient Support	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/10/31	23 : 54	GlobeNewswire Inc.	Tevogen Bio Expands on Microsoft Partnership to Integrate Machine Learning and AI into Preclinical Processes, Accelerating Drug Development and Reducing Costs	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/10/30	04 : 28	GlobeNewswire Inc.	Tevogen Bio Reports Nasdaq Listing Compliance as CEO Reaffirms His Commitment in Bridging the Information Gap About the Company	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/10/30	01 : 43	GlobeNewswire Inc.	Tevogen Bio Signs Letter of Intent With CD8 Technology to Build Up to a $50 Million R&D and Manufacturing Facility; No Impact on Shareholder Equity	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/10/26	06 : 34	GlobeNewswire Inc.	Tevogen Bio Provides Additional Guidance on Introduction of T Cell Therapy for Oncology and Specialty Care Therapeutic Areas	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/10/23	21 : 35	GlobeNewswire Inc.	Tevogen Bio’s Effort in Artificial Intelligence, Tevogen AI, Joins Microsoft for Startups, Begins Accelerating drug Development	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/10/23	03 : 30	GlobeNewswire Inc.	Tevogen Bio To Provide Timelines Associated with Recently Announced Revenue Forecast and Updates on Operational Readiness This Week	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/10/22	04 : 58	GlobeNewswire Inc.	Tevogen Bio Specialty Care Reports Top-Line Revenue Forecast of Nearly $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $18 Billion and $22 Billion	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/10/22	02 : 56	GlobeNewswire Inc.	Tevogen Bio Provides Clarity on CSO Share Sales to Satisfy Tax Obligations, Expects Additional Forecast and Progress Updates in the Coming Days	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/10/19	11 : 46	GlobeNewswire Inc.	Tevogen CEO Expresses Gratitude for Unprecedented Public Support of Company’s Business Model of Commercial Success Through Patient Accessibility and Reaffirms His Commitment to Share Additional Details in the Coming Days	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/10/17	22 : 32	GlobeNewswire Inc.	Tevogen Bio Oncology Reports Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion; Forecasts for Non-Oncology Therapeutic Areas to Follow	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/10/17	20 : 54	GlobeNewswire Inc.	Tevogen Investors Congratulate on Prestigious Recognition of Pioneering Biopharma Business Model, Breakthrough Innovations, Building Assets Estimated to Exceed $10 Billion	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/10/17	05 : 30	GlobeNewswire Inc.	Tevogen Bio Thanks Warren Township for Proclamation Honoring CEO Dr. Ryan Saadi, Nobel Peace Prize Nomination, and the Company's Mission to Address Health Inequality	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/10/16	03 : 30	GlobeNewswire Inc.	Tevogen Bio Takes Lead in Developing Cell Therapies Designed to Eradicate Post Procedure Human Papilloma Virus in Women with Precancerous Cervical Lesions	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/10/16	00 : 36	GlobeNewswire Inc.	Tevogen Bio Highlights the Publication of Promising Trial Data as the CEO Expresses Optimism About the Company’s Scientific Breakthrough in Mainstreaming Cell Therapy Through a New Class of Off-the-Shelf T-Cell Therapies, Manufactured and Stored for Imme	NASDAQ:TVGN	Tevogen Bio Holdings Inc

Showing the most relevant articles for your search:NASDAQ:TVGN

1 2 3 4 次へ >>

US Dollar vs Yen

Financial Select Sector

Health Care Select Sector

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約